Integral Role of Nutrition in CCA

June 2024, Vol 5, No 2

Nutrition is an integral part of cancer care, particularly for cancer of gastrointestinal origin, such as cholangiocarcinoma (CCA).1

At the 2024 Cholangiocarcinoma Foundation Annual Conference, Shelby Yaceczko, MS, RDN-AP, CNSC, an advanced practice dietitian nutritionist, reviewed nutrient metabolism relevant to CCA, nutrition impact symptoms during CCA treatment, and diet principles to follow.

At the outset, Ms Yaceczko stressed the importance of nutrition and that it is often not prioritized or overlooked during disease management. She noted, “If we get a diagnosis of a life-changing condition [such as CCA], we often forget that if we don’t have the proper fuel and are not eating and nourishing our body, we cannot get to the next step.”

Nutrition-impact symptoms may arise due to the disease itself and/or those emergent with CCA treatment, including surgery and chemotherapy, and the role of nutrition in CCA largely focuses on managing these related symptoms.

Ms Yaceczko stated that the disease and/or treatment can affect appetite and food interest, impacting overall nutrition. Moreover, nutritional needs are dynamic and can change during the disease, with nutritional status worsening as it progresses. She recommended maintaining a nutritional log during the cancer continuum to better track diets that worked well and those that compromised nutrition to make necessary adjustments.

Inadequate nutrition over time can lead to malnutrition, which is associated with negative outcomes, such as feeling tired and weak, and may make the patient unable to complete cancer therapy or fight infection. Therefore, the main goals of nutritional interventions are to maintain energy and overall well-being, eat a balanced diet focused on nutrient-dense foods for fuel, prevent loss of muscle mass, and maintain defenses against infection.

Nutrition-impact symptoms may be specific to the CCA treatment received, including the type of surgery (eg, removal of bile ducts, partial liver resection, Whipple procedure, liver bypass, liver transplantation, stent placement), chemotherapy, radiation, and combination therapy.

Nutritional considerations after surgery include delayed gastric emptying, diabetes, malabsorption, malnutrition, loss of appetite, early satiety, abdominal discomfort, altered bowel habits, and pancreatic insufficiency.

Nutritional considerations during cancer treatment include loss of appetite, mouth sores, dry mouth, unintentional weight loss, vomiting, diarrhea and/or constipation, taste or smell changes, and nausea.

Ms Yaceczko made suggestions for improving appetite, such as making mealtime more social, honoring daily food preferences, trying favorite foods, and recreating settings that will make the patient eat more consistently and more frequently instead of just pressurizing them to eat, and replacing liquid meals with more solid foods.2

References

  1. Hormati A, Hajrezaei Z, Jazi K, et al. Gastrointestinal and pancreatic hepatobiliary cancers: a comprehensive review on epidemiology and risk factors worldwide. Middle East J Dig Dis. 2022;14(1):5-23.
  2. Yaceczko S. Nutrition and cholangiocarcinoma: what’s the scoop? Cholangiocarcinoma Foundation 2024 Annual Conference. Presented April 17-19, 2024. Accessed June 6, 2024.

Related Items

Artificial Intelligence and Clinical Experience: Shaping the Future of CCA Care
June/July 2026, Vol 7, No 2
A look at how the synergy between artificial intelligence and clinical expertise is potentially shaping the outlook of cholangiocarcinoma care.
Cholangiocarcinoma Clinical Trials: Debunking Myths, Uncovering Facts, and Exploring Opportunities
June/July 2026, Vol 7, No 2
Uncover how clinical trials are transforming cholangiocarcinoma treatment, offering patients personalized therapies, expanded options, and new hope for the future.
The Changing Paradigm of Cellular Immunotherapy in Cholangiocarcinoma
June/July 2026, Vol 7, No 2
Explore how cellular immunotherapy, from tumor-infiltrating lymphocytes to circulating tumor-reactive T cells, is expanding the treatment landscape for cholangiocarcinoma.
Antibody-Drug Conjugates in Biliary Tract Cancers
June/July 2026, Vol 7, No 2
Antibody-drug conjugates show potential in cancer treatment and may signal new possibilities for biliary tract cancer patients in this significant exploration.
Advancing Hepatic Arterial Infusion Pump Chemotherapy for Intrahepatic Cholangiocarcinoma: Boosting Survival and Quality of Life
June/July 2026, Vol 7, No 2
Hepatic arterial infusion pump chemotherapy is transforming treatment for intrahepatic cholangiocarcinoma by improving survival rates and enhancing quality of life.
Exploring Protein Arginine Methyltransferases as Promising Therapeutic Targets in Cholangiocarcinoma
June/July 2026, Vol 7, No 2
Targeting protein arginine methyltransferases offers a promising new approach to combat cholangiocarcinoma by suppressing tumor growth and enhancing immune responses.
Advancing CAR T Cell Therapy for Cholangiocarcinoma
June/July 2026, Vol 7, No 2
Discover how emergent research on CAR T-cell therapy is paving the way for new possibilities in cholangiocarcinoma treatment.
Overcoming Therapeutic Resistance in Cholangiocarcinoma: Exploring Combination Strategies and Adaptive Lineage States
June/July 2026, Vol 7, No 2
Cutting-edge research on therapeutic resistance and innovative combination strategies is adding new possibilities to the fight against cholangiocarcinoma.
Biomarker Discovery and Early Detection in CCA
June 2025, Vol 6, No 2
Experts unveiled a roadmap for translating cutting-edge biomarkers into clinical practice, paving the way for improved early detection and personalized care in high-risk populations with cholangiocarcinoma (CCA).
Translational Science and Discovery in CCA
June 2025, Vol 6, No 2
Leading experts explored groundbreaking advancements in tumor microenvironments, biomarker validation, and innovative therapies, paving the way for transformative precision medicine in cholangiocarcinoma (CCA) care.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Profession or Role
Primary Specialty or Disease State